CRT 2025

CardioTube Interview

CardioTube Interview | Late-Breaking Clinical Trial | Electrosurgical Leaflet Modification To Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement In Failing Native And Bioprosthetic Valves: The TELLTALE Trial

Interviewer(s)

• 

  Giorgio A. Medranda, MD

  Structural Interventional Cardiologist
  NYU Langone Hospital - Long Island
  Glen Cove, New York, United States

  Disclosure(s): No financial relationships to disclose

Interviewee(s)

• 

  Toby Rogers, MD, PhD

  Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
  Georgetown University and MedStar Washington Hospital Center
  Washington, District of Columbia, United States

  Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)